BPC-157 and Thymosin Beta-4 Interaction

Synergistic
Researched 95% confidence

BPC-157 and Thymosin Beta-4 have a synergistic interaction with 95% confidence. Complementary healing mechanisms—Tβ4 promotes cell migration and angiogenesis while BPC-157 enhances gastric protection. Both compounds affect the blood vessels, so monitoring these systems is recommended.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity
vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic
View full profile

Thymosin Beta-4

43-Amino Acid Regenerative Peptide | Tissue Repair & Healing

Direct systemic delivery provides optimal bioavailability and distribution to target tissues for comprehensive regenerative effects including angiogenesis, cell migration, and differentiation..

Half-life: Dose-dependent; relatively short (exact values not established) Typical dose: 2-6mg per injection (varies by protocol and severity) healing, immune, longevity
View full profile

Combined Organ Load

Blood Vessels
low

Frequently Asked Questions

Can I take BPC-157 with Thymosin Beta-4?

Yes, BPC-157 and Thymosin Beta-4 can generally be taken together. Complementary healing mechanisms—Tβ4 promotes cell migration and angiogenesis while BPC-157 enhances gastric protection.

Is BPC-157 and Thymosin Beta-4 safe together?

Based on documented research, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between BPC-157 and Thymosin Beta-4?

Complementary healing mechanisms—Tβ4 promotes cell migration and angiogenesis while BPC-157 enhances gastric protection. This assessment has 95% confidence and is based on documented research data.

How should I time BPC-157 and Thymosin Beta-4?

BPC-157 has a half-life of <30 minutes and Thymosin Beta-4 has a half-life of Dose-dependent; relatively short (exact values not established). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs Thymosin Beta-4

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.